BIO Wants Expanded Accelerated Approval In PDUFA Instead Of Progressive Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
While it would not grab as much attention as creating a whole new approval pathway, BIO believes tinkering with accelerated approval to give the regulations more clarity and increase its use still could generate the change it wants at FDA.